Cite
HARVARD Citation
Rueda, A. et al. (2015). A phase II study to evaluate lenalidomide in combination with metronomic-dose cyclophosphamide in patients with heavily pretreated classical Hodgkin lymphoma. Acta oncologica. pp. 933-938. [Online].